Coibamide A Induces mTOR-Independent Autophagy and Cell Death in Human Glioblastoma Cells

Coibamide A is an N-methyl-stabilized depsipeptide that was isolated from a marine cyanobacterium as part of an International Cooperative Biodiversity Groups (ICBG) program based in Panama. Previous testing of coibamide A in the NCI in vitro 60 cancer cell line panel revealed a potent anti-proliferative response and “COMPARE-negative” profile indicative of a unique mechanism of action. We report that coibamide A is a more potent and efficacious cytotoxin than was previously appreciated, inducing concentration- and time-dependent cytotoxicity (EC50<100 nM) in human U87-MG and SF-295 glioblastoma cells and mouse embryonic fibroblasts (MEFs). This activity was lost upon linearization of the molecule, highlighting the importance of the cyclized structure for both anti-proliferative and cytotoxic responses. We show that coibamide A induces autophagosome accumulation in human glioblastoma cell types and MEFs via an mTOR-independent mechanism; no change was observed in the phosphorylation state of ULK1 (Ser-757), p70 S6K1 (Thr-389), S6 ribosomal protein (Ser-235/236) and 4EBP-1 (Thr-37/46). Coibamide A also induces morphologically and biochemically distinct forms of cell death according to cell type. SF-295 glioblastoma cells showed caspase-3 activation and evidence of apoptotic cell death in a pattern that was also seen in wild-type and autophagy-deficient (ATG5-null) MEFs. In contrast, cell death in U87-MG glioblastoma cells was characterized by extensive cytoplasmic vacuolization and lacked clear apoptotic features. Cell death was attenuated, but still triggered, in Apaf-1-null MEFs lacking a functional mitochondria-mediated apoptotic pathway. From the study of ATG5-null MEFs we conclude that a conventional autophagy response is not required for coibamide A-induced cell death, but likely occurs in dying cells in response to treatment. Coibamide A represents a natural product scaffold with potential for the study of mTOR-independent signaling and cell death mechanisms in apoptotic-resistant cancer cells.

[1]  I. Slaninová,et al.  Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine , 2012, Biological chemistry.

[2]  S. Eschenburg,et al.  A molecular view on signal transduction by the apoptosome. , 2012, Cellular signalling.

[3]  Mónica Suárez Korsnes.  Yessotoxin as a Tool to Study Induction of Multiple Cell Death Pathways , 2012, Toxins.

[4]  C. Watson,et al.  Killing a cancer: what are the alternatives? , 2012, Nature Reviews Cancer.

[5]  P. Marks,et al.  Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death , 2012, Proceedings of the National Academy of Sciences.

[6]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[7]  Xuejun Jiang,et al.  Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. , 2011, Molecular cell.

[8]  P. Codogno,et al.  Autophagic cell death: Loch Ness monster or endangered species? , 2011, Autophagy.

[9]  W. Weiss,et al.  Autophagy and Akt promote survival in glioma , 2011, Autophagy.

[10]  D. Sabatini,et al.  Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. , 2011, Cancer cell.

[11]  C. Brennan.  Genomic Profiles of Glioma , 2011, Current neurology and neuroscience reports.

[12]  Jonathan Puddick,et al.  Lagunamides A and B: cytotoxic and antimalarial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. , 2010, Journal of natural products.

[13]  Kay Hofmann,et al.  Selective autophagy: ubiquitin-mediated recognition and beyond , 2010, Nature Cell Biology.

[14]  A. Cuervo,et al.  Autophagy gone awry in neurodegenerative diseases , 2010, Nature Neuroscience.

[15]  S. Barth,et al.  Autophagy: assays and artifacts , 2010, The Journal of pathology.

[16]  C. Krakstad,et al.  Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics , 2010, Molecular Cancer.

[17]  C. Chresta,et al.  Simultaneous inhibition of mTORC1 and mTORC2 by mTOR kinase inhibitor AZD8055 induces autophagy and cell death in cancer cells , 2010, Autophagy.

[18]  Daniel J Klionsky,et al.  Mammalian autophagy: core molecular machinery and signaling regulation. , 2010, Current opinion in cell biology.

[19]  Lisa L. Smith,et al.  AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. , 2010, Cancer research.

[20]  I. Nabi,et al.  Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling , 2009, PloS one.

[21]  D. Sabatini,et al.  Rapamycin inhibits mTORC1, but not completely , 2009, Autophagy.

[22]  W. Gerwick,et al.  Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms. , 2009, Journal of natural products.

[23]  D. Sabatini,et al.  An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.

[24]  S. Kondo,et al.  Inhibition of autophagy at a late stage enhances imatinib‐induced cytotoxicity in human malignant glioma cells , 2009, International journal of cancer.

[25]  Susan M. Chang,et al.  Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  T. Molinski,et al.  Drug development from marine natural products , 2009, Nature Reviews Drug Discovery.

[27]  Caterina Giannini,et al.  Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Rebecca A. Medina,et al.  Coibamide A, a potent antiproliferative cyclic depsipeptide from the Panamanian marine cyanobacterium Leptolyngbya sp. , 2008, Journal of the American Chemical Society.

[29]  N. Mizushima,et al.  How to Interpret LC3 Immunoblotting , 2007, Autophagy.

[30]  J. Ishmael,et al.  Survival of Swiss-Webster mouse cerebellar granule neurons is promoted by a combination of potassium channel blockers. , 2007, Toxicology letters.

[31]  Lik Tong Tan,et al.  Bioactive natural products from marine cyanobacteria for drug discovery. , 2007, Phytochemistry.

[32]  G. Mills,et al.  Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. , 2005, Cancer research.

[33]  A. Tolkovsky,et al.  The Dynamics of Autophagy Visualised in Live Cells: from Autophagosome Formation to Fusion with Endo/lysosomes , 2005, Autophagy.

[34]  Takeshi Tokuhisa,et al.  The role of autophagy during the early neonatal starvation period , 2004, Nature.

[35]  P. Marks,et al.  Apoptotic and autophagic cell death induced by histone deacetylase inhibitors , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Camouzis,et al.  On the Dynamics of , 2003 .

[37]  M. Colombo,et al.  A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. , 2001, Journal of cell science.

[38]  Takeshi Tokuhisa,et al.  Dissection of Autophagosome Formation Using Apg5-Deficient Mouse Embryonic Stem Cells , 2001, The Journal of cell biology.

[39]  W. Gerwick,et al.  Nitrogen-containing metabolites from marine cyanobacteria. , 2001, The Alkaloids. Chemistry and biology.

[40]  N. Mizushima,et al.  A New Protein Conjugation System in Human , 1998, The Journal of Biological Chemistry.

[41]  G. de Murcia,et al.  Importance of Poly(ADP-ribose) Polymerase and Its Cleavage in Apoptosis , 1998, The Journal of Biological Chemistry.

[42]  P. Houghton,et al.  Studies on the mechanism of resistance to rapamycin in human cancer cells. , 1998, Molecular pharmacology.

[43]  T. Mak,et al.  Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development , 1998, Cell.

[44]  Y. Moriyama,et al.  Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. , 1998, Cell structure and function.

[45]  K. Altendorf,et al.  Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.